Qingdao Vland Biotech INC
SSE:603739
Qingdao Vland Biotech INC
SSE:603739
Price:
14.74
CNY
-8.1%
Market Closed
Market Cap:
¥3.7B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Qingdao Vland Biotech INC
SSE:603739
|
CN |
|
C
|
Computer and Technologies Holdings Ltd
HKEX:46
|
HK |
|
Volution Group PLC
LSE:FAN
|
UK |
|
Natura &Co Holding SA
OTC:NTCOY
|
BR |
|
R
|
Rex Trueform Group Ltd
JSE:RTO
|
ZA |
|
Atom Hoteles Socimi SA
MAD:YATO
|
ES |
|
Lem Holding SA
SIX:LEHN
|
CH |
|
Comefly Outdoor Co Ltd
SSE:603908
|
CN |
|
V
|
Viet Nam Ocean Shipping JSC
VN:VOS
|
VN |
|
L
|
Limin Group Co Ltd
SZSE:002734
|
CN |
|
G
|
Guangdong Delian Group Co Ltd
SZSE:002666
|
CN |
|
Broadwind Inc
NASDAQ:BWEN
|
US |
|
Xinxiang Chemical Fiber Co Ltd
SZSE:000949
|
CN |
|
Destination XL Group Inc
NASDAQ:DXLG
|
US |
|
Casa Holdings Ltd
SGX:C04
|
SG |
|
Dolby Laboratories Inc
NYSE:DLB
|
US |
|
F
|
Fiera Milano SpA
LSE:0EGH
|
IT |
|
Gansu Yasheng Industrial Group Co Ltd
SSE:600108
|
CN |
Relative Value
The Relative Value of one
Qingdao Vland Biotech INC
stock under the Base Case scenario is
hidden
CNY.
Compared to the current market price of 14.74 CNY,
Qingdao Vland Biotech INC
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Qingdao Vland Biotech INC Relative Value
HIDDEN
Multiples Across Competitors
Competitors Multiples
Qingdao Vland Biotech INC Competitors
Qingdao Vland Biotech INC Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
|
Qingdao Vland Biotech INC
SSE:603739
|
3.7B CNY | 2.7 | 44.6 | 28.2 | 28.2 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
362.5B USD | 5.9 | 86.6 | 14.4 | 20 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
187.5B USD | 5.1 | 24.3 | 14.1 | 14.1 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
170.3B USD | 5.8 | 20 | 12.5 | 15.5 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
115.3B USD | 9.6 | 29.2 | 21.9 | 22.9 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
77.5B USD | 5.4 | 17.2 | 12.6 | 14.4 | |
| AU |
|
CSL Ltd
ASX:CSL
|
66.8B AUD | 3.1 | 34.3 | 11.3 | 14.3 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 | |
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
41.3B USD | 11.1 | 131.9 | 73.8 | 82 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
